Taipei Exchange - Delayed Quote TWD

Level Biotechnology Inc. (3118.TWO)

34.00
+0.10
+(0.29%)
At close: June 4 at 1:13:26 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
729,991
731,347
660,611
593,013
677,279
Cost of Revenue
497,505
494,219
441,066
390,421
444,775
Gross Profit
232,486
237,128
219,545
202,592
232,504
Operating Expense
166,080
161,871
151,751
137,688
153,540
Operating Income
66,406
75,257
67,794
64,904
78,964
Net Non Operating Interest Income Expense
4,763
5,165
4,848
2,126
1,288
Pretax Income
80,234
81,125
78,650
73,157
84,893
Tax Provision
14,743
16,314
15,745
14,691
16,714
Net Income Common Stockholders
65,491
64,811
62,905
58,466
68,179
Diluted NI Available to Com Stockholders
65,491
64,811
62,905
58,466
68,179
Basic EPS
2.02
2.00
1.94
1.80
2.10
Diluted EPS
2.01
1.99
1.93
1.79
2.09
Basic Average Shares
32,465.46
32,453
32,453
32,453
32,453
Diluted Average Shares
32,662.46
32,650
32,657
32,669
32,666
Total Expenses
663,585
656,090
592,817
528,109
598,315
Net Income from Continuing & Discontinued Operation
65,491
64,811
62,905
58,466
68,179
Normalized Income
65,465.70
64,762.27
63,098.55
58,466
68,283.41
Interest Income
5,027
5,445
5,180
2,474
1,666
Interest Expense
264
280
332
348
378
Net Interest Income
4,763
5,165
4,848
2,126
1,288
EBIT
80,498
81,405
78,982
73,505
85,271
EBITDA
102,196
102,620
98,704
93,005
105,064
Reconciled Cost of Revenue
497,505
494,219
441,066
390,421
444,775
Reconciled Depreciation
21,698
21,215
19,722
19,500
19,793
Net Income from Continuing Operation Net Minority Interest
65,491
64,811
62,905
58,466
68,179
Total Unusual Items Excluding Goodwill
31
61
-242
0
-130
Total Unusual Items
31
61
-242
0
-130
Normalized EBITDA
102,165
102,559
98,946
93,005
105,194
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5.70
12.27
-48.45
0
-25.59
12/31/2021 - 8/20/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1777.TWO SYN-TECH Chem. & Pharm. Co., Ltd.
88.10
+0.11%
 
1733.TW Apex Biotechnology Corp.
30.85
+1.82%
 
6662.TWO BioLASCO Taiwan Co., Ltd.
33.85
-0.44%
 
4130.TWO Genovate Biotechnology Co., Ltd.
21.40
+0.47%
 
3176.TWO Medigen Biotechnology Corp.
31.35
+2.79%
 
3164.TW GenMont Biotech Incorporation
20.30
+0.50%
 
6461.TWO Intech Biopharm Corporation
18.00
-1.10%
 
4192.TWO SynCore Biotechnology Co.,Ltd
29.00
0.00%
 
4131.TWO NeoCore Technology Co., Ltd.
35.00
+0.72%
 
6872.TWO NaviFUS Corp.
24.00
-0.21%